Tel Aviv Medical Center
9 clinical trials · Sponsor
◉ Watch Tel Aviv Medical Center
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer (NCT06407310) | Tel Aviv Medical Center | 2024-07-01 |
| Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma (NCT05973903) | Tel Aviv Medical Center | 2024-06-01 |
| Internet-based CBIT for Children With Chronic Tics (NCT04087616) | Tel Aviv Medical Center | 2019-07-01 |
Track Tel Aviv Medical Center automatically
Every clearance here is in the API, with alerts when new ones post.